Serena has been the Chair of the Greater China Private Funds practice since 2021 and served as the Deputy Chair of the firm’s Global Private Funds Group for four years. She represents global and regional fund managers and institutional investors in the formation of private equity, growth capital, venture capital, co-investment, and private credit funds across a wide range of sectors, including consumer, technology/TMT, financial services, and healthcare. Her representative fund manager clients include Affirma Capital, Ascendent Capital Partners, BAI Capital, Boyu Capital, CBC Group, DCP Capital, GLP, Hony Capital, KHL Capital, Kowloon Nights, Morgan Stanley Private Equity Asia, ORIX Asia Capital, Ping An, SoftBank Ventures Asia, and Taiwania Capital. Serena frequently advises fund managers on arrangements among principals, carried interest plans, employee co-investments, and regulatory and compliance matters. She also has deep experience in fund-of-funds, funds-of-one, and separate accounts.
Serena advises real estate fund managers on the formation of real estate funds and joint ventures, with experience across asset classes, including offices, logistics, industrial parks, residential, hospitality, and retail. Her representative real estate fund manager clients include GLP, Hony Capital, SKP, and Sino-Ocean Capital.
Serena also advises on GP-led and LP-led fund secondary transactions, including continuation vehicles, stapled secondaries, and secondary purchases of LP interests.
In addition, Serena regularly represents institutional investors, including sovereign wealth funds, insurers, family offices, and asset management firms.
Year after year, Serena is widely acknowledged by legal directories as one of the leading private funds partners in Asia. Recent recognition includes being ranked as a leading partner by Chambers Global (2019-2026), Chambers Asia-Pacific (2019-2021), Chambers Greater China (2022-2026), and Legal 500 Asia Pacific (2020-2026). She was featured in ALB’s “Asia’s 40 Under 40” list of the most accomplished young lawyers in 2018. Under Serena’s leadership, the Private Funds Team in Asia advised Asia-based GPs on more than 70 fund formation transactions in 2025, with an aggregate transaction value of US$122 billion. The team was also shortlisted for the 2021 PEI Awards for Asia Law Firm of the Year in the Fund Formation category.
Serena has been recognized by clients as a “highly diligent and talented” practitioner with “excellent professional knowledge and a strong commercial sense” and their “go-to lawyer for fund formation work that has a Chinese component.” Clients have highlighted her as “an ideal partner” who “understands the differences between offshore funds and RMB funds and the differences between international investors and Chinese investors,” and “has the outstanding ability to design optimal structures, bridge gaps, and find solutions.”
Serena is a Registered Foreign Lawyer (New York Qualified) with the Law Society of Hong Kong. She has over 17 years of experience practicing law in New York and China.
A China-focused private equity firm’s US$2 billion fund formation
Represented a China-focused private equity firm in its formation of China buyout fund in excess of US$2 billion.
A U.S. private equity firm’s RMB¥2 billion fund formation
Represented a US private equity firm in its formation of an RMB-denominated buyout and growth capital fund in excess of RMB¥2 billion.
A China-focused private equity firm’s US$2 billion fund formation
Represented a China-focused private equity firm in its formation of a China buyout and growth capital fund in excess of US$2 billion.
A China-focused private equity firm’s fund formation
Represented a China-focused private equity firm in its formation of a China venture capital fund.
An Asia-focused private equity firm’s fund formation
Represented an Asia-focused private equity firm in its formation of an RMB-denominated China buyout fund.
A China-focused private equity firm’s US$500 million fund formation
Represented a China-focused private equity firm in its formation of a China buyout and growth capital fund in excess of US$500 million.
A China-focused private equity firm’s fund formation
Represented a China-focused private equity firm in its formation of a global health care buyout and growth capital fund.
An Asia-focused private equity firm’s US$600 million fund formation
Represented an Asia-focused private equity firm in its formation of an Asia growth capital fund in excess of US$600 million.
An Asia-focused private equity firm’s $1.5 billion fund formation
Represented an Asia-focused private equity firm in its formation of an Asia buyout fund in excess of $1.5 billion.
An India-focused private equity firm’s fund formation
Represented an India-focused private equity firm in its formation of an India growth capital fund.
An Asia-focused private equity firm’s fund formation
Represented an Asia-focused private equity firm in its formation of an Asia buyout fund.
Top Chinese insurance companies’ investments
Represented several top Chinese insurance companies in their investments in private equity funds.
Top Chinese banks’ investments
Represented several top Chinese banks in their investments in private equity funds.
Top Chinese asset management firms’ investments
Represented several top Chinese asset management firms in their investments in private equity funds.
A U.S.-listed company’s investments
Represented one of the largest U.S.-listed companies in its investment in multiple private equity funds.
Ranked: leading lawyer in China for Investment Funds (International Firms)
Chambers Global 2023-2024
Ranked: China Investment Funds: Private Equity (International Firms)
Ranked: leading lawyer in China for Investment Funds (International Firms)
Recommended: China Investment Funds: Foreign Firm
Recommended: Hong Kong Investment Funds
Named: 40 Under 40 list of The Next Generation of Asia’s Lawyers